Internal Medicine, Hematology · Panama City, FL
NPI
1922246982
Since 2009
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
615 N Bonita Ave # 2-F
Panama City, FL, 32401
Phone (850) 804-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.4M
484,200 services
Medicare patients, 2024
1,423
Average age 75
Drug cost, 2024
$7.3M
2,576 prescriptions
Company payments, 2025
$2,818
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andrew M Weber was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 63,060 times for 14 patients. In total Andrew M Weber billed 484,200 services in 168 codes, and Medicare paid $7.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-06.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 63,060 | 14 | $0.21 | $13K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 59,900 | 36 | $2.32 | $139K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 30,300 | 27 | $0.11 | $3,340 |
| J0897 Injection, denosumab, 1 mg | Office | 23,220 | 85 | $20.10 | $467K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,800 | 28 | $44.24 | $965K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 21,240 | 14 | $39.38 | $837K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 18,600 | 142 | $15.69 | $292K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,100 | 11 | $0.06 | $722 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 11,250 | 12 | $0.76 | $8,595 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 9,740 | 78 | $0.10 | $974 |
| J0185 Injection, aprepitant, 1 mg | Office | 9,230 | 15 | $1.35 | $13K |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,676 | 13 | $0.08 | $708 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,600 | 21 | $6.29 | $35K |
| 85025 Blood Count | Office | 4,891 | 1,295 | $7.60 | $37K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 4,800 | 15 | $0.07 | $321 |
By year: 2022 $7.2M for 538,887 services; 2023 $8.7M for 548,946 services; 2024 $7.4M for 484,200 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 4,891 | 1,295 | $7.60 | $37K |
| 36415 Venipuncture Blood Collection | 4,183 | 1,276 | $8.65 | $36K |
| 80053 Clinical Chemistry | 4,041 | 1,249 | $10.33 | $42K |
| 83540 Clinical Chemistry | 1,815 | 827 | $6.33 | $11K |
| 82728 Clinical Chemistry | 1,814 | 827 | $13.34 | $24K |
| 83550 Clinical Chemistry | 1,814 | 827 | $8.56 | $16K |
| 86023 Immunoassay | 930 | 152 | $12.21 | $11K |
| 83615 Clinical Chemistry | 530 | 304 | $5.92 | $3,138 |
| 83735 Clinical Chemistry | 434 | 109 | $6.57 | $2,851 |
| 81002 Clinical Chemistry | 73 | 54 | $3.41 | $249 |
Medicare prescription drug claims, 2024
In 2024, the drug Andrew M Weber prescribed most often to Medicare patients was Anastrozole, with 248 prescriptions and refills. In total Andrew M Weber wrote 2,576 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 248 | 563 | 73 | $5,603 |
| Eliquis Apixaban | 114 | 147 | 23 | $84K |
| Fentanyl Generic | 109 | 109 | 18 | $14K |
| Prochlorperazine Maleate Generic | 108 | 108 | 54 | $2,145 |
| Ondansetron Odt Ondansetron | 107 | 107 | 68 | $1,689 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 104 | 104 | 30 | $3,105 |
| Oxycodone Hcl Generic | 100 | 100 | 28 | $1,619 |
| Acyclovir Generic | 93 | 106 | 21 | $731 |
| Hydroxyurea Generic | 90 | 200 | 26 | $2,237 |
| Lenalidomide Generic | 75 | 75 | 12 | $751K |
| Revlimid Lenalidomide | 74 | 74 | 11 | $1.1M |
| Imbruvica Ibrutinib | 69 | 69 | Under 11 | $1.1M |
| Ondansetron Hcl Generic | 62 | 70 | 30 | $1,186 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 62 | 62 | 16 | $2,285 |
| Dexamethasone Generic | 60 | 96 | 25 | $1,481 |
Brand drugs: 604 claims; generic drugs: 1,972 claims; opioid claims: 424.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew M Weber $2,818 ($2,818 in general payments such as food, travel and fees) from 41 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $245.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $245 |
| Celgene Corporation BMY | 8 | $236 |
| Merck Sharp & Dohme LLC MRK | 9 | $194 |
| Celltrion USA Inc. 068270.KS | 3 | $182 |
| Daiichi Sankyo Inc. 4568.T | 7 | $173 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $161 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $142 |
| BeOne Medicines USA, Inc. ONC | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $77.87 |
| Genentech USA, Inc. ROG.SW | 4 | $77.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.